Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DXR NYSE:ELMD NYSE:INFU NASDAQ:INGN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXRDaxor$9.88+2.2%$10.50$7.19▼$14.76$49.77M0.299,434 shs3,230 shsELMDElectromed$26.78-0.3%$24.54$17.73▼$30.73$221.56M0.3955,831 shs1,100 shsINFUInfuSystem$8.80-1.9%$9.69$5.08▼$11.04$179.42M1.49128,860 shs84,804 shsINGNInogen$7.31+1.6%$6.50$5.34▼$9.13$199.81M1.64282,718 shs365,792 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXRDaxor-4.28%-11.74%+9.50%-22.06%+28.85%ELMDElectromed+3.55%+4.47%+12.95%-7.73%+22.15%INFUInfuSystem-11.54%-11.45%-4.17%+16.19%+88.84%INGNInogen+1.13%+1.13%+5.74%+27.03%+0.28%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXRDaxor$9.88+2.2%$10.50$7.19▼$14.76$49.77M0.299,434 shs3,230 shsELMDElectromed$26.78-0.3%$24.54$17.73▼$30.73$221.56M0.3955,831 shs1,100 shsINFUInfuSystem$8.80-1.9%$9.69$5.08▼$11.04$179.42M1.49128,860 shs84,804 shsINGNInogen$7.31+1.6%$6.50$5.34▼$9.13$199.81M1.64282,718 shs365,792 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXRDaxor-4.28%-11.74%+9.50%-22.06%+28.85%ELMDElectromed+3.55%+4.47%+12.95%-7.73%+22.15%INFUInfuSystem-11.54%-11.45%-4.17%+16.19%+88.84%INGNInogen+1.13%+1.13%+5.74%+27.03%+0.28%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDXRDaxor 2.50Moderate BuyN/AN/AELMDElectromed 3.00Buy$36.6736.94% UpsideINFUInfuSystem 2.67Moderate Buy$15.0070.38% UpsideINGNInogen 2.67Moderate Buy$13.0077.94% UpsideCurrent Analyst Ratings BreakdownLatest DXR, ELMD, INFU, and INGN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/7/2026INGNInogen Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy3/27/2026DXRDaxor Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)2/24/2026INFUInfuSystem Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$14.00 ➝ $15.002/11/2026DXRDaxor Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy2/11/2026ELMDElectromed Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$38.00(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDXRDaxorN/AN/AN/AN/AN/AN/AELMDElectromed$68.86M3.22$0.65 per share41.36$5.10 per share5.25INFUInfuSystem$143.44M1.24$0.69 per share12.79$2.47 per share3.56INGNInogen$348.67M0.57N/AN/A$7.08 per share1.03Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDXRDaxorN/AN/AN/AN/AN/AN/AN/AN/AN/AELMDElectromed$5.15M$1.0335.70N/AN/A11.34%15.71%13.37%N/AINFUInfuSystem$870K$0.32148.1128.40N/A1.12%2.78%1.41%N/AINGNInogen-$22.75M-$0.86N/AN/AN/A-6.52%-11.56%-7.42%N/ALatest DXR, ELMD, INFU, and INGN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026INGNInogen-$0.24-$0.30-$0.06-$0.30$82.35 million$85.11 million3/2/2026Q2 2025DXRDaxorN/A-$0.1010N/A-$0.1010N/AN/A2/24/2026Q4 2025INGNInogen-$0.36-$0.26+$0.10-$0.26$82.00 million$81.72 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDXRDaxorN/AN/AN/AN/AN/AELMDElectromedN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/AINGNInogenN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDXRDaxorN/AN/AN/AELMDElectromedN/A5.104.74INFUInfuSystem0.501.981.59INGNInogenN/A3.122.71Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDXRDaxor1.34%ELMDElectromed40.82%INFUInfuSystem71.13%INGNInogen89.94%Insider OwnershipCompanyInsider OwnershipDXRDaxor59.50%ELMDElectromed10.50%INFUInfuSystem10.80%INGNInogen1.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDXRDaxor375.04 million2.04 millionNot OptionableELMDElectromed1608.28 million7.36 millionOptionableINFUInfuSystem41020.19 million19.10 millionOptionableINGNInogen1,03027.33 million26.93 millionOptionableDXR, ELMD, INFU, and INGN HeadlinesRecent News About These CompaniesInogen Maintains Buy Rating as Analyst Reaffirms $12 Price Target on Solid Q1 and Growth CatalystsMay 8 at 6:11 AM | tipranks.comInogen (INGN) Q1 2026 Earnings TranscriptMay 7 at 12:27 AM | fool.comInogen Q1 Earnings Call HighlightsMay 7 at 12:05 AM | marketbeat.comInogen (INGN) Reports Q1 Loss, Beats Revenue EstimatesMay 7 at 8:11 PM | zacks.comInogen Announces First Quarter 2026 Financial ResultsMay 7 at 4:05 PM | businesswire.comInogen (INGN) Projected to Post Quarterly Earnings on ThursdayMay 5 at 4:27 AM | americanbankingnews.comInogen (INGN) Projected to Post Earnings on ThursdayApril 30, 2026 | marketbeat.comWe're Not Very Worried About Inogen's (NASDAQ:INGN) Cash Burn RateApril 29, 2026 | finance.yahoo.comInogen (NASDAQ:INGN) Stock Price Passes Above 50 Day Moving Average - Here's What HappenedApril 24, 2026 | marketbeat.comInogen to Report First Quarter 2026 Financial Results on May 7, 2026April 24, 2026 | finance.yahoo.comHere's Why You Should Retain Inogen Stock in Your Portfolio for NowApril 22, 2026 | zacks.comInogen Unveils Growth Plan at Needham Conference: New CFO, Voxi 5, Simeox and Aurora Mask PushApril 16, 2026 | marketbeat.comFreedom Capital Upgrades Inogen (NASDAQ:INGN) to Strong-BuyApril 8, 2026 | marketbeat.comInogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?April 8, 2026 | zacks.comFreedom Broker initiates coverage of Inogen (INGN) with buy recommendationApril 8, 2026 | msn.comInogen Appoints Jamali to Board, Enters Cooperation Agreement With Activist InvestorApril 6, 2026 | marketwatch.comInogen Announces the Appointment of Vafa Jamali to Board of DirectorsApril 6, 2026 | businesswire.comInogen makes three appointments to exec teamMarch 31, 2026 | hmenews.comHInogen Announces Participation in the 25th Annual Needham Virtual Healthcare ConferenceMarch 31, 2026 | businesswire.comInogen Announces Leadership Appointments Designed to Accelerate Next Phase of GrowthMarch 30, 2026 | lasvegassun.comLInogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 30, 2026 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDXR, ELMD, INFU, and INGN Company DescriptionsDaxor NASDAQ:DXR$9.88 +0.22 (+2.23%) As of 11:27 AM Eastern This is a fair market value price provided by Massive. Learn more.Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.Electromed NYSE:ELMD$26.78 -0.09 (-0.32%) As of 11:28 AM Eastern This is a fair market value price provided by Massive. Learn more.Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.InfuSystem NYSE:INFU$8.80 -0.17 (-1.85%) As of 11:28 AM Eastern This is a fair market value price provided by Massive. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Inogen NASDAQ:INGN$7.31 +0.12 (+1.61%) As of 11:28 AM Eastern This is a fair market value price provided by Massive. Learn more.Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Wells Fargo’s Comeback Is Real—But Not Risk-Free IonQ Just Posted a Breakout Quarter—But 1 Problem Remains SLB’s Tough Quarter Masks a Powerful Long-Term Shift Super Micro Surges Over 20% as Margins Soar, Sales Fall Short Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
